Menu
Search
|

Menu

Close
X

Bristol-Myers Squibb Co BMY.N (New York Stock Exchange)

47.49 USD
-0.67 (-1.39%)
As of Mar 25
Previous Close 48.16
Open 48.15
Volume 4,988,974
3m Avg Volume 4,313,364
Today’s High 48.20
Today’s Low 47.38
52 Week High 63.75
52 Week Low 44.30
Shares Outstanding (mil) 1,639.93
Market Capitalization (mil) 106,283.60
Forward P/E 23.62
Dividend (Yield %) 0.39 ( 2.41 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.29 Mean rating from 14 analysts

KEY STATS

Revenue (mm, USD)
FY18
22,561
FY17
20,776
FY16
19,427
EPS (USD)
FY18
3.039
FY17
2.358
FY16
2.653
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
23.62
32.54
Price to Sales (TTM)
vs sector
5.25
8.39
Price to Book (MRQ)
vs sector
7.23
5.27
Price to Cash Flow (TTM)
vs sector
19.77
24.12
Total Debt to Equity (MRQ)
vs sector
55.90
16.02
LT Debt to Equity (MRQ)
vs sector
47.02
11.35
Return on Investment (TTM)
vs sector
18.60
13.82
Return on Equity (TTM)
vs sector
30.97
15.24

EXECUTIVE LEADERSHIP

Giovanni Caforio
Chairman of the Board, Chief Executive Officer, Since 2017
Salary: $1,587,500.00
Bonus: $3,899,090.00
Charles Bancroft
Chief Financial Officer, Executive Vice President - Global Business Operations, Since 2016
Salary: $997,294.00
Bonus: $1,887,000.00
Ann Judge
Chief Human Resource Officer, Senior Vice President, Since 2016
Salary: --
Bonus: --
Thomas Lynch
Chief Scientific Officer, Executive Vice President, Since 2017
Salary: $796,154.00
Bonus: $1,576,710.00
Sandra Leung
Executive Vice President, General Counsel, Since 2015
Salary: $947,436.00
Bonus: $1,493,890.00

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

430 E 29th St Fl 14
NEW YORK   NY   10016-8367

Phone: +1212.5464000

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world.

SPONSORED STORIES